NCT07413263尚未招募不适用
Impact of Tyrosine Kinase Inhibitors on Glucose and Lipid Metabolism in Chronic Myeloid Leukemia
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 75
- 主要终点
- Change in HbA1c levels in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
研究概览
简要总结
to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism
详细描述
to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism and how danger they drugs be
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •CML patients free medical history
排除标准
- 未提供
结局指标
主要结局
Change in HbA1c levels in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
时间窗: Baseline and 3, 6, 9, and 12 months
Assessment of change in HbA1c levels in CML patients treated with TKIs.
次要结局
- Change in lipid profile in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors(Baseline and 3, 6, 9, and 12 months)
研究者
Nancy Atef Abdou Mousa
Resident Doctor of Internal Medicine
Assiut University
相似试验
已完成
不适用
Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease PatientsDiabetesChronic Kidney DiseaseNCT07302464Ain Shams University60
已完成
不适用
Effect of a Low Advanced Glycation End Products Diet of Patients With Type 2 Diabetes MellitusType 2 DiabetesNCT07303842InCor Heart Institute36
招募中
不适用
Impact of the New Generation Anti-diabetic Drugs on Diabetic RetinopathyNCT07351786Sara A Belal70
已完成
3 期
SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and AnemiaChronic Kidney DiseaseAnemiaNCT07344922Mansoura University100
招募中
2 期
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal SyndromeHeart FailureAcute Kidney InjuryNCT07273838Yale University130